Personalized omalizumab treatment improves clinical benefit in patients with chronic spontaneous urticaria.

J Allergy Clin Immunol

Centre for Human Drug Research, Leiden, The Netherlands; Department of Dermatology Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. Electronic address:

Published: December 2018

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2018.07.032DOI Listing

Publication Analysis

Top Keywords

personalized omalizumab
4
omalizumab treatment
4
treatment improves
4
improves clinical
4
clinical benefit
4
benefit patients
4
patients chronic
4
chronic spontaneous
4
spontaneous urticaria
4
personalized
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!